U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543809) titled 'Tiaozhong-Yiqi-Tang for Substance Withdrawal Syndrome: A Randomized Controlled Clinical Trial' on April 15.
Brief Summary: This is a randomized controlled clinical trial to explore the efficacy and mechanism of Tiaozhong-Yiqi Decoction (TZYD) in treating substance withdrawal syndrome, combining network pharmacology analysis and clinical validation.
A total of 80 patients meeting the diagnostic criteria for withdrawal syndrome were enrolled and randomly divided into two groups: the TZYD intervention group (n=40) received Tiaozhong-Yiqi Decoction 200mL twice daily for 3 consecutive months, combined with routine care; the control gro...